Thackray Helen M.

CIK 00015897253 companiesGAITHERSBURG, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001589725

Recent Transactions

50 trades

Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2025-03-31$7.50/sh−7,525→ 377,318 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19+125,950→ 390,939 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-19$7.39/sh−6,096→ 384,843 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2024-12-19+260,950→ 260,950 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-12-14$7.53/sh−7,150→ 264,989 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-05-14$5.86/sh+30,000→ 272,139 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2024-03-31$5.08/sh−7,525→ 242,139 total
Disposition to Issuer
ImmunoGen, Inc.
Common Stock
2024-02-12−3,074→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−44,000→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−19,597→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Restricted Stock Unit
2024-02-12−13,090→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Stock Option (Right to Buy)
2024-02-12−32,066→ 0 total
Disposition to Issuer
ImmunoGen, Inc.
Deferred Share Unit
2024-02-12−40,932→ 0 total
Award
ImmunoGen, Inc.
Common Stock
2023-12-29$29.65/sh+252→ 3,074 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-19$6.05/sh−5,580→ 249,664 total
Tax Payment
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14$6.43/sh−3,031→ 255,244 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-12-14+51,000→ 258,275 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2023-12-14+238,000→ 238,000 total
Award
ImmunoGen, Inc.
Common Stock
2023-09-29$15.87/sh+472→ 2,822 total
Award
ImmunoGen, Inc.
Common Stock
2023-06-30$18.87/sh+397→ 2,350 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2023-06-14+19,597→ 19,597 total
Award
ImmunoGen, Inc.
Restricted Stock Unit
2023-06-14+13,090→ 13,090 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2023-04-03$8.29/sh−7,000→ 207,275 total
Award
ImmunoGen, Inc.
Common Stock
2023-03-31$3.84/sh+1,953→ 1,953 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-19+81,000→ 214,275 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2022-12-19+238,000→ 238,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-12-15$10.89/sh−3,125→ 133,275 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2022-06-15$3.37/sh+32,066→ 32,066 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2022-06-15+10,932→ 40,932 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2022-04-01$16.20/sh−7,600→ 136,400 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-12-14+205,000→ 205,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-12-14+44,000→ 144,000 total
Award
ImmunoGen, Inc.
Stock Option (right to buy)
2021-09-22$5.97/sh+44,000→ 44,000 total
Award
ImmunoGen, Inc.
Deferred Share Unit
2021-09-22+30,000→ 30,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2021-03-31+400,000→ 400,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2021-03-31+100,000→ 100,000 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2021-01-20+34,500→ 183,115 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2021-01-20+69,000→ 69,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2020-05-12+40,000→ 40,000 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2020-01-22+120,000→ 120,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Non-Qualified Stock Option
2019-09-20+40,000→ 40,000 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2019-01-17+100,000→ 100,000 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2017-12-08$15.01/sh−2,000→ 148,615 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2017-09-18$13.00/sh−2,000→ 150,615 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2017-05-25$15.57/sh−2,000→ 152,615 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2017-05-19$12.14/sh−2,000→ 154,615 total
Award
CRESCENT BIOPHARMA, INC.$CBIO
Employee Stock Option (right to buy)
2017-01-04+75,000→ 75,000 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2016-10-03$7.01/sh−100→ 156,615 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2016-10-03$7.00/sh−3,900→ 156,715 total
Sale
CRESCENT BIOPHARMA, INC.$CBIO
Common Stock
2016-07-20$8.00/sh−2,000→ 160,615 total

Companies

Recent Filings

Address

C/O GLYCOMIMETICS, INC. 401 PROFESSIONAL DRIVE, SUITE 250

GAITHERSBURG, MD, 20879

View on SEC.gov